Physician profile
Bidisha Ray
NPI 1881878429
$1,156.13
in general payments reported to CMS, 2019-2025
11 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $19.80 · 2021: $136 · 2022: $138 · 2023: $191 · 2024: $268 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $272.99 | 2024-2025 | Arista Ah Flexitip, Bd Onclarity |
| Gynesonics, INC. | $124.99 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $124.66 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $120.36 | 2025 | |
| Abbvie INC. | $106.38 | 2019 | |
| Viiv Healthcare Company | $105.44 | 2023 | Apretude |
| Medtronic, INC. | $88.91 | 2021-2025 | Symplicity G3 |
| Hologic Sales and Service, LLC | $72.40 | 2022-2023 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Olympus America INC. | $67.38 | 2021 | |
| Minerva Surgical, INC | $52.82 | 2019-2023 | |
| Amag Pharmaceuticals, INC. | $19.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bidisha Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.